These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21570356)

  • 41. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
    Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
    [No Abstract]   [Full Text] [Related]  

  • 42. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV-1 superinfection--a word of caution.
    Goulder PJ; Walker BD
    N Engl J Med; 2002 Sep; 347(10):756-8. PubMed ID: 12213949
    [No Abstract]   [Full Text] [Related]  

  • 44. Bangkok after RV144.
    von Bubnoff A
    IAVI Rep; 2013; 17(3):4-8, 14. PubMed ID: 24199317
    [No Abstract]   [Full Text] [Related]  

  • 45. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
    Andersson KM; Stover J
    Vaccine; 2011 Aug; 29(36):6092-9. PubMed ID: 21703322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on HIV vaccines.
    Meldorf M; Corey L
    STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poxvirus vector-based HIV vaccines.
    Pantaleo G; Esteban M; Jacobs B; Tartaglia J
    Curr Opin HIV AIDS; 2010 Sep; 5(5):391-6. PubMed ID: 20978379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV/AIDS vaccines: a need for new concepts?
    Girard MP; Bansal GP
    Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV vaccine trials begin in Oxford.
    Fazal A
    BMJ; 2000 Sep; 321(7261):591. PubMed ID: 10977831
    [No Abstract]   [Full Text] [Related]  

  • 50. Cape Town connections.
    Dumiak M
    IAVI Rep; 2014; 18(4):4-10. PubMed ID: 25625172
    [No Abstract]   [Full Text] [Related]  

  • 51. Support for the RV144 HIV vaccine trial.
    AIDS Vaccine Advocacy Coalition
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15250069
    [No Abstract]   [Full Text] [Related]  

  • 52. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa.
    Jaspan HB; Gray GE; Robinson AK; Coovadia HM; Bekker LG
    S Afr Med J; 2005 Sep; 95(9):685-7. PubMed ID: 16327928
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV-1C vaccine trial planned for South Africa.
    Ramsay S
    Lancet; 2000 Oct; 356(9238):1336. PubMed ID: 11073034
    [No Abstract]   [Full Text] [Related]  

  • 54. HIV vaccine development--improving on natural immunity.
    Johnston MI; Fauci AS
    N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
    [No Abstract]   [Full Text] [Related]  

  • 55. Statistical evaluation of HIV vaccines in early clinical trials.
    Moodie Z; Rossini AJ; Hudgens MG; Gilbert PB; Self SG; Russell ND
    Contemp Clin Trials; 2006 Apr; 27(2):147-60. PubMed ID: 16426900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 58. Current strategies and limitations of HIV vaccines.
    Kawalekar OU; Shedlock DJ; Weiner DB
    Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Volunteers sought for NIH AIDS vaccine study.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16329177
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical experience with therapeutic AIDS vaccines.
    Bourinbaiar AS; Abulafia-Lapid R
    Expert Rev Vaccines; 2005 Jun; 4(3):289-304. PubMed ID: 16026245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.